# Nuclide record f-18-fdopa (drug). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/drugs/f-18-fdopa/>
  a schema:Drug ;
  nuclide:kind "drug" ;
  schema:identifier "f-18-fdopa" ;
  schema:name "Fluorodopa F-18"@en ;
  schema:alternateName "18F-FDOPA"@en, "6-[18F]fluoro-L-DOPA"@en, "Fluorodopa F 18 Injection"@en ;
  schema:description "A tracer originally built to look at brain dopamine cells in suspected Parkinson's disease. Because certain hormone-producing tumours use the same chemical machinery, doctors also use it, off-label, to find those tumours -- especially adrenal gland tumours called pheochromocytoma."@en ;
  schema:url <https://nuclide.cc/drugs/f-18-fdopa/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/200655s000lbl.pdf>, <https://pmc.ncbi.nlm.nih.gov/articles/PMC10728412/>, <https://snmmi.org/common/Uploaded%20files/Web/Clinical%20Practice/Procedure%20Standards/2019/EANM%20SNMMI%20guideline%20on%20radionuclide%20imaging%20of%20phaeochromocytoma%20and%20paraganglioma.pdf> ;
  nuclide:status "approved" ;
  nuclide:tag "amino acid PET", "off-label oncology use", "PPGL" ;
  nuclide:modality "PET tracer" ;
  nuclide:approval "US 2019: PET imaging to visualise dopaminergic nerve terminals in the striatum in adults with suspected Parkinsonian syndromes (neurological indication; oncology use is off-label)" ;
  nuclide:related <https://nuclide.cc/drugs/cu-64-dotatate/>, <https://nuclide.cc/drugs/ga-68-dotatoc/>, <https://nuclide.cc/drugs/i-123-mibg/>, <https://nuclide.cc/drugs/f-18-fet/>, <https://nuclide.cc/isotopes/f-18/>, <https://nuclide.cc/isotopes/ga-68/>, <https://nuclide.cc/isotopes/i-123/> ;
  nuclide:indications <https://nuclide.cc/indications/pheochromocytoma-paraganglioma/>, <https://nuclide.cc/indications/metastatic-ppgl/>, <https://nuclide.cc/indications/neuroendocrine/>, <https://nuclide.cc/indications/glioblastoma/> ;
  nuclide:technologies <https://nuclide.cc/technologies/pet/>, <https://nuclide.cc/technologies/pet-ct/> .